{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DEXA&page=5", "query": { "intervention": "DEXA", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 359, "total_pages": 36, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DEXA&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=DEXA&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T21:25:13.251Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02920671", "title": "Muscle OXPHOS and Nutrient Homeostasis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mitochondrial Diseases", "Obesity" ], "interventions": [ { "name": "Tracer-enhanced oral glucose tolerance test (OGTT*)", "type": "OTHER" }, { "name": "Muscle MRI", "type": "OTHER" }, { "name": "Dual energy x-ray absorptiometry (DXA)", "type": "OTHER" }, { "name": "Questionnaires", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 45, "start_date": "2017-02-14", "completion_date": "2024-08-28", "has_results": false, "last_update_posted_date": "2024-09-03", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02920671" }, { "nct_id": "NCT04956302", "title": "Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Plasma Cell Myeloma", "Refractory Plasma Cell Myeloma" ], "interventions": [ { "name": "Bortezomib", "type": "DRUG" }, { "name": "Daratumumab and Hyaluronidase-fihj", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Panobinostat Lactate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abdullah Khan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1, "start_date": "2021-09-27", "completion_date": "2022-06-16", "has_results": false, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04956302" }, { "nct_id": "NCT04566328", "title": "Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plasma Cell Myeloma", "RISS Stage I Plasma Cell Myeloma", "RISS Stage II Plasma Cell Myeloma" ], "interventions": [ { "name": "Bortezomib", "type": "DRUG" }, { "name": "Daratumumab and Hyaluronidase-fihj", "type": "BIOLOGICAL" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "ECOG-ACRIN Cancer Research Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1450, "start_date": "2021-02-24", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 640, "location_summary": "Anchorage, Alaska • Phoenix, Arizona • Tucson, Arizona + 456 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04566328" }, { "nct_id": "NCT06657209", "title": "Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2", "Diabetes", "Type 2 Diabetes", "Pre Diabetes" ], "interventions": [ { "name": "Insulin resistance testing", "type": "PROCEDURE" }, { "name": "OGTT", "type": "PROCEDURE" }, { "name": "Fat biopsy", "type": "PROCEDURE" }, { "name": "DXA scan", "type": "RADIATION" }, { "name": "MRI", "type": "PROCEDURE" }, { "name": "1H-MRS", "type": "PROCEDURE" }, { "name": "Tirzepatide", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 104, "start_date": "2025-01-13", "completion_date": "2027-12-15", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 2, "location_summary": "Palo Alto, California • Stanford, California", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06657209" }, { "nct_id": "NCT06325644", "title": "Well-Formulated Ketogenic Diet Polycystic Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Polycystic Kidney Disease" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" }, { "name": "Ketone/Glucose Monitoring", "type": "BIOLOGICAL" }, { "name": "CGM/CKM", "type": "BIOLOGICAL" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Body Composition", "type": "OTHER" }, { "name": "Change in glomerular filtration rate (mg/mmol) via magnetic resonance imaging (MRI) .", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2024-06-01", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325644" }, { "nct_id": "NCT03798678", "title": "CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Multiple Myeloma", "Refractory Multiple Myeloma" ], "interventions": [ { "name": "Carfilzomib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Telaglenastat Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2019-07-08", "completion_date": "2027-07-16", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 5, "location_summary": "New Haven, Connecticut • Tampa, Florida • Rochester, Minnesota + 2 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03798678" }, { "nct_id": "NCT00892515", "title": "Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Healthy, no Evidence of Disease" ], "interventions": [ { "name": "exercise intervention", "type": "BEHAVIORAL" }, { "name": "counseling intervention", "type": "OTHER" }, { "name": "gas chromatography", "type": "OTHER" }, { "name": "immunoenzyme technique", "type": "OTHER" }, { "name": "immunologic technique", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "mass spectrometry", "type": "OTHER" }, { "name": "physiologic testing", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "survey administration", "type": "OTHER" }, { "name": "dual x-ray absorptometry", "type": "PROCEDURE" }, { "name": "magnetic resonance imaging", "type": "PROCEDURE" }, { "name": "study of high risk factors", "type": "PROCEDURE" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "PROCEDURE" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "FEMALE", "summary": "18 Years to 35 Years · Female only" }, "enrollment_count": 183, "start_date": "2008-10", "completion_date": "2016-05-20", "has_results": false, "last_update_posted_date": "2020-04-16", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00892515" }, { "nct_id": "NCT04756401", "title": "Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Plasma Cell Myeloma", "Refractory Plasma Cell Myeloma" ], "interventions": [ { "name": "Carfilzomib", "type": "DRUG" }, { "name": "Daratumumab", "type": "BIOLOGICAL" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Selinexor", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2022-12-08", "completion_date": "2027-12-30", "has_results": true, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 4, "location_summary": "Hackensack, New Jersey • Syracuse, New York • Chapel Hill, North Carolina + 1 more", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "Syracuse", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04756401" }, { "nct_id": "NCT06080932", "title": "Ketogenic Intervention in Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Ketosis" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" }, { "name": "NIH Toolbox", "type": "OTHER" }, { "name": "gradCPT", "type": "OTHER" }, { "name": "Resting-state fMRI", "type": "OTHER" }, { "name": "Task-fMRI", "type": "OTHER" }, { "name": "CGM/CKM", "type": "OTHER" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Sleep Monitoring", "type": "OTHER" }, { "name": "Ketone/Glucose Monitoring", "type": "BIOLOGICAL" }, { "name": "Body Composition", "type": "OTHER" }, { "name": "PHQ-9", "type": "BEHAVIORAL" }, { "name": "WHO-5", "type": "BEHAVIORAL" }, { "name": "SKID", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL", "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 30, "start_date": "2023-02-20", "completion_date": "2024-12-21", "has_results": false, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06080932" }, { "nct_id": "NCT02244814", "title": "Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gestational Diabetes Mellitus" ], "interventions": [ { "name": "Low Carbohydrate/Conventional", "type": "BEHAVIORAL" }, { "name": "Choosing Healthy Options in Carbohydrate Energy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "36 Years", "sex": "ALL", "summary": "Up to 36 Years" }, "enrollment_count": 105, "start_date": "2015-07", "completion_date": "2020-11", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-10-21T21:25:13.251Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02244814" } ] }